Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.65 USD
+0.85 (5.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.65 USD
+0.85 (5.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Zacks News
Prudential (PRU) Lags Q1 Earnings Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -1.27% and 46.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYX
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Oscar Health, Inc. (OSCR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
by Zacks Equity Research
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
November Marks Best Month Since 2022: 4 Best Sectors & Stock Picks
by Sanghamitra Saha
November marked an exceptional month for stocks. Interest rate-sensitive sectors and stocks like Udemy (UDMY), Oscar Health (OSCR), Rocky Brands (RCKY) and Landsea Homes (LSEA) outperformed in the month.
Oscar Health, Inc. (OSCR) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Oscar Health, Inc. (OSCR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Oscar Health, Inc. (OSCR) Could Rally 59.34%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Oscar Health, Inc. (OSCR) points to a 59.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
New Strong Buy Stocks for October 20th
by Zacks Equity Research
OSCR, IMGN, AFRM, ACVA and SOLO have been added to the Zacks Rank #1 (Strong Buy) List on October 20, 2023.
Reasons to Hold American International (AIG) Stock for Now
by Zacks Equity Research
Strong General Insurance business, improving premiums and cost-cutting efforts poise American International (AIG) well for growth.
Here's Why You Should Retain MetLife (MET) in Your Portfolio
by Zacks Equity Research
MetLife's (MET) growing partnerships, strong U.S. and Latin America segments, and cost-cutting efforts are aiding its margins.
Oscar Health, Inc. (OSCR) Stock Jumps 56.3%: Will It Continue to Soar?
by Zacks Equity Research
Oscar Health, Inc. (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Investors Should Invest in CNO Financial (CNO) Stock Now
by Zacks Equity Research
Strong direct-to-consumer life sales, improving annuity collected premiums and increased Medicare enrolment poise CNO Financial (CNO) well for growth.
Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Prudential (PRU) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -5.84% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Old Republic International (ORI) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 63.27% and 1.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -19.74% and 5.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.96% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American International Group (AIG) Q3 Earnings Surpass Estimates
by Zacks Equity Research
American International Group (AIG) delivered earnings and revenue surprises of 11.86% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PCB Bancorp (PCB) Q3 Earnings Miss Estimates
by Zacks Equity Research
PCB Bancorp (PCB) delivered earnings and revenue surprises of -32.35% and 2.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) & Oscar Health Boost Presence in Philadelphia
by Zacks Equity Research
Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 14.34% and 2.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?